Department of Radiology: Nuclear Medicine

The faculty of the Emory Division of Nuclear Medicine & Molecular Imaging offers the highest quality patient care, incorporating the latest knowledge, innovation and equipment. Nuclear Medicine not only uses the most advanced methods, but also helps set the bar for the field. All of our physicians are board certified in nuclear medicine, and some are double-boarded in other fields, particularly Radiology; many have national and international reputations in their fields.

Equipment includes PET/CT and SPECT/CT scanners at Emory University Hospital (Clifton campus) and Emory University Hospital Midtown. We offer a wide variety of specialized nuclear medicine therapies including that for thyroid cancer, bone cancer pain palliation, lymphoma, neuroendocrine tumors and
Y-90 liver therapy in cooperation with Interventional Radiology. Research devices at our disposal include a high-resolution brain PET scanner, micro-PET/CT for animal research, and a research cyclotron. A full range of nuclear medicine and PET/CT services are also provided at Grady Memorial Hospital, Emory Johns Creek Hospital, and the Atlanta VA Medical Center. The Division is integrally involved in research as well as close collaboration with colleagues in Radiology, Cardiology and the Emory Winship Cancer Institute. Our faculty are principal investigators and co-investigators on many research grants including those sponsored by the NIH.

    - David M. Schuster, MD
                                          Associate Professor of Radiology and
             Imaging Sciences
                                            Director, Division of Nuclear Medicine
                     and Molecular Imaging

Lectures:
Clinical Utility of Positron Emission Tomography Scanning in Breast Cancer Management

Hybrid Imaging: SPECT/CT

Lecturer: David Schuster, MD
2013 Georgia Society of Nuclear Medicine Technologists Annual Meeting
http://www.gsnmt.org/

_________________________________________________________________

Lecture: Clinical Utility of PET Scanning in Breast Cancer

Lecturer: David Schuster, MD
New Perspectives in Breast Cancer 11/2012
Bethesda, Maryland

_________________________________________________________________

Lecture: GI Bleeding

Lecturer: David Schuster, MD
RSNA 11/2012
__________________________________________________________________

Lecture: CT, MRI, 18F-FDG-PET, or 111In-Octreotide? (and what is MIBG?)

Lecturer: David Schuster, MD
Winship Cancer Institute's 3rd Annual State-of-the-Art Multidisciplinary Management of Gastrointestinal Cancers Symposium 10/2012

__________________________________________________________________

Lecture: Dose Calculation and Post-Therapy Imaging

Lecturer - David Schuster, MD
SNM 2012 meeting
Miami, Fl

Details of Presentaion

__________________________________________________________________

Lecture: Perfect Storm

Lecturer - David Schuster, MD
Emory Symposium on Image-guided Cancer Therapies
March 17, 2012

____________________________________________________________________

Lectures:

CNS hybrid imaging: Anatomy, variant,Urgent Findings

Head & Neck Hybrid imaging: Anatomy, variant, Urgent Findings

Chest Hybrid imaging: Anatomy, variant, Urgent Findings

Abdominal and Pelvic Hybrid imaging: Anatomy, variant, Urgent Findings

Common Musculoskeletal correlative findings on Hybrid imaging

Lecturer - David Schuster, MD
2nd Kuwait Society of Nuclear Medicine Meeting (KSNM) March 6, 2012

Southeastern Chapter of the Society of Nuclear Medicine
1st Place Best Resident/Basic Science Trainee Poster

Drs. Plaxton, Halkar and Barron won the 1st Place Best Resident/Basic Science Trainee Poster for their poster on "FDG PET/CT Characteristics of Adrenal Benign and Malignant Lesions" at the 2012 Southeastern Chapter Society of Nuclear Medicine Annual Meeting.

Southeastern Chapter of the Society of Nuclear Medicine

Marshall Brucer Award
The Southeastern Chapter of the Society of Nuclear Medicine (SECSNM) honored Raghuveer K. Halkar, MD, Chief, General Nuclear Medicine at Emory University Hospital and Professor of Radiology and Imaging Sciences, with the presentation of the Marshall Brucer Award, the highest honor that the SECSNM can bestow upon a member. The Brucer Award was presented to Dr. Halkar at the September 21-24, 2012 SECSNM Annual Meeting, recognizing his many years of service to nuclear medicine as well as his leadership in organized medicine at the state, chapter and national level.

SNM 2012
This year, Miami, Fl hosted the 2012 Society of Nuclear Medicine (SNM) Annual Conference on June 9-13th. The SNM is recognized as the premier educational and networking event in molecular imaging and nuclear medicine. Emory's Department of Radiology and Imaging Sciences was well recognized at the annual meeting, reflective of our ability to stay at the leading-edge of technology and help to define the future of Molecular Imaging.

Read more in the July Rad Report

Society of Nuclear Medicine- Young Investor Award

Dr. Amzat 's abstract entitled "Extraprostatic recurrent prostate carcinoma detection with synthetic amino acid PET/CT surpasses imaging with 111Indium-capromab-pendetide plus diagnostic CT" received second place prize in Basic Clinical in Nuclear Oncology from the Society of Nuclear Medicine. The award identifies promising young investigators working in Nuclear Oncology related fields in nuclear medicine.

RSNA Professionalism Committee
Bruce Barron, MD

The Board of Directors of the Radiological Society of North America (RSNA) has appointed Dr. Barron to serve as a member of the Professional Committee beginning at the conclusion of the 2011 Annual Meeting.

According to the RSNA, the committee is responsible for staying current with the American Board of Medical Specialties/Council of Medical Specialty Societies/Accreditation Council for Graduate Medical Education requirements for competency in professionalism. The committee periodically reviews RSNA educational activities and resources. They will determine if RSNA strengthen radiologists� understanding of and ability to carry out their responsibilities as professionals.

Radiology Research Study Section Committee for RSNA
David Schuster, MD

Dr. Schuster has been selected to serve on the Radiology Research Study Section Committee for RSNA. This committee is responsible for evaluating, scoring, and providing written critiques for the Foundation's radiology research grant applications. The RSNA review process is patterned after the NIH grant review process. Study section members prepare written reviews and submit preliminary scores for assigned grant applications, and they attend a study section meeting to discuss and score all Foundation research grant applications.

Harrison CE, Barron BJ. MIBG Superscan of Metastatic Paraganglioma Occurring With Neurofibromatosis Type 1. Clinical Nuclear Medicine. June 2013. 38(6):459-462.

Schuster DM, Taleghani PA, Nieh PT, Master VA, Amzat R, Savir-Baruch B, Halkar RK, Fox T, Osunkoya AO, Moreno CS, Nye JA, Yu W, Fei B, Wang Z, Chen Z, Goodman MM.Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging. 2013;3(1):85-96. Epub 2013 Jan 5.

Chen SA, Schuster DM, Mister D, Liu T, Godette K, Torres MA. Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):309-14.

Moncayo, Valeria M; Martin, Diego R; Sarmiento, Juan M.; Zbytek, Blazej; Fox, Tim PhD; Schuster, David M. 111In OctreoScan SPECT-MRI Fusion for the Detection of a Pancreatic Insulinoma, Clinical Nuclear Medicine:, March 2012 - Volume 37 - Issue 3 - p e53-e56

Oka S, Okudaira H, Yoshida Y, Schuster DM, Goodman MM, Shirakami Y. Transport mechanisms of trans-1-amino-3-[14C]fluorocyclobutane-1-carboxylic acid in prostate cancer cells. Nuclear Medicine and Biology 2012;39(1):109-19

Harrison, C. E.; Barron, B. J. MIBG Superscan of Metastatic Paraganglioma Occurring with Neurofibromatosis Type I. Clinical Nuclear Medicine. 38(6):459-462, June 2013.

Mikell J., Herr, K and Barron B. PET/CT Findings in emphysematous cystitis. J. Clin Nuc Med. March 2013.

Brandon D, Barron BJ. Dermatological. PET-CT and PET-MRI in Oncology: A Practical Guide. Editors: Peller P, Subramaniam R, Guermazi A Springer, Edition 1; 2013. 229-252. ISBN 3642011381.

Reavey HE, Aarsvold HN, Margeanu DG, Brandon D, Nye JA, Galt JR. Left-ventricle phantom in air in the quality field of view of the D530C. Poster presented at the SNMMI Mid-Winter Meeting 2013, New Orleans, LA.

Plaxton N, Bonta DV, Brandon D. Image-based prediction of the need for additional radiation safety precautions in thyroid cancer patients treated with I-131. Poster presented at the SNMMI Mid-Winter Meeting 2013, New Orleans, LA.

Chen SA, Schuster DM, Mister D, Liu T, Godette K, Torres MA. Radiation Field Design and Patterns of Locoregional Recurrence Following Definitive Radiotherapy for Breast Cancer. International Journal of Radiation Oncology-Biology-Physics 2013;85(2):309-314.

Schuster DM, Taleghani PA, Nieh PT, Master VM, Amzat R, Savir-Baruch B, Halkar RK, Fox T, Osunkoya AO, Moreno CS, Nye JA, Yu W, Fei B, Wang Z, Chen Z, Goodman MM. Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake. American Journal of Nuclear Medicine and Molecular Imaging 2013;3(1):85-96

Ocean AJ, Pennington KL, Guarino MJ, Sheik A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O�Neil BH, Hall N, Montero AJ, Kauh J, Gold DV, Horne H, Wegener WA, Goldenberg DM. Fractionated Radioimmunotherapy With 90Y-Clivatuzumab Tetraxetan and Low-Dose Gemcitabine is Active in Advanced Pancreatic Cancer: A Phase 1 Trial. Cancer 2012 Nov; 118 (22): 5497-506. Epub 8 May 2012.

Esteves F, Bonta D, Lucaj R and Barron B. Nuclear Imaging in Cardiothoracic Disease. In Cardiothoracis Surgery Review, Franco KL and Thourani VH, eds. Wolkers Kluwer/ Lippincott William and Wilkins. Philadelphia 2012. (932-948).

Esteves FP, Garcia EV. 2012. PET and PET/CT imaging. In Iskandrian AE and Garcia EV (Ed), Braunwald�s Companion: Nuclear Cardiac Imaging. Philadelphia, PA. (417-448).

Garcia EV, Klein JL, Esteves FP, et al. LVX: A novel decision support system for cardiac image interpretation and reporting. J Nucl Cardiol 2012 (Suppl);19(4):838.

Garcia EV, Taylor A, Folks R, Manatunga D, Halkar R, Savir-Baruch B, Dubovsky E.. iRENEX: a clinically informed decision support system for the interpretation of ⁹⁹mTc-MAG3 scans to detect renal obstruction. Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1483-91.

Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, Sperling MR, Gardiner I, Erba G, Fried I, Jacobs M, Vinters HV, Mintzer S, Kieburtz K; Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.JAMA. 2012 Mar 7;307(9):922-30.

Moncayo V, Brandon D, Lee D, Bonta D, Halkar R. Recognizing the artifacts and minimizing untoward effects caused by failed or complicated radiopharmaceutical injections. Journal of Nuclear Medicine 2012 May: 53S: 1037P. (Abstr.)